Abstract:Graphical and Lay Summary NADPH‐dependent oxidoreductases are important catalysts for production of chiral compounds, but insufficient supply of expensive nicotinamide cofactors have prevented their widespread exploitation. In this study, the authors developed a metabolic engineering strategy and a multienzyme modulation strategy for a NADPH‐dependent glufosinate dehydrogenases (GluDH) whole‐cell biocatalytic system to enhance intracellular NADP+ pool and catalytic efficiency. The cofactor self‐sufficient whole‐cell biocatalystic system was successfully applied for the asymmetric synthesis of L‐phosphinothricin, afformed a super high space‐time yield without the need to add exogenous cofactors. The engineering strategy might serve as a useful approach for constructing a cofactor self‐sufficient system of other oxidoreductases. NAD(P)H‐dependent oxidoreductases are crucial biocatalysts for synthesizing chiral compounds. Yet, the industrial implementation of enzymatic redox reactions is often hampered by an insufficient supply of expensive nicotinamide cofactors. Here, a cofactor self‐sufficient whole‐cell biocatalyst was developed for the enzymatic asymmetric reduction of 2‐oxo‐4‐[(hydroxy)(‐methyl)phosphinyl] butyric acid (PPO) to L‐phosphinothricin (L‐PPT). The endogenous NADP+ pool was significantly enhanced by regulating Preiss‐Handler pathway toward NAD(H) synthesis and, in the meantime, introducing NAD kinase to phosphorylate NAD(H) toward NADP+. The intracellular NADP(H) concentration displayed a 2.97‐fold increase with the strategy compared with the wild‐type strain. Furthermore, a recombinant multi‐enzyme cascade biocatalytic system was constructed based on the Escherichia coli chassis. In order to balance multi‐enzyme co‐expression levels, the strategy of modulating rate‐limiting enzyme PmGluDH by RBS strengths regulation successfully increased the catalytic efficiency of PPO conversion. Finally, the cofactor self‐sufficient whole‐cell biocatalyst effectively converted 300 mM PPO to L‐PPT in 2 h without the need to add exogenous cofactors, resulting in a 2.3‐fold increase in PPO conversion (%) from 43% to 100%, with a high space‐time yield of 706.2 g L−1 d−1 and 99.9% ee. Overall, this work demonstrates a technological example for constructing a cofactor self‐sufficient system for NADPH‐dependent redox biocatalysis.

Biocatalytic Asymmetric Synthesis of L-Phosphinothricin Using a One-Pot Three Enzyme System and a Continuous Substrate Fed-Batch Strategy

One-Pot Two-Stage Biocatalytic Cascade to Produce l-Phosphinothricin by Two Enantioselective Complementary Aminotransferases at High Substrate Loading via a Deracemization Process

Artificial Biocatalytic Cascade with Three Enzymes in One Pot for Asymmetric Synthesis of Chiral Unnatural Amino Acids

Enzyme Cascade with Four Enzymes in One Pot for the Synthesis of L‐Phosphinothricin

Development of an aminotransferase‐driven biocatalytic cascade for deracemization of d,l‐phosphinothricin

Driving Transamination Irreversible by Decomposing Byproduct Α-Ketoglutarate into Ethylene Using Ethylene-Forming Enzyme

Computer-Aided Flexible Loops Engineering of Glutamate Dehydrogenase for Asymmetric Synthesis of Chiral Pesticides l-phosphinothricin

Efficient L-phosphinothricin production by engineered Escherichia coli co-expressing glutamate dehydrogenase, glucose dehydrogenase and NAD kinase with NADPH regeneration

Identification of a novel thermostable transaminase and its application in L-phosphinothricin biosynthesis

A novel NADH-dependent leucine dehydrogenase for multi-step cascade synthesis of L-phosphinothricin

Efficient Reductive Amination Process for Enantioselective Synthesis of L-phosphinothricin Applying Engineered Glutamate Dehydrogenase

Enzyme Cascade for Biocatalytic Deracemization of D,L-phosphinothricin

Identification of efficient amine transaminase and applicability in dual transaminases cascade for synthesis of L-phosphinothricin

Design of a cofactor self‐sufficient whole‐cell biocatalyst for enzymatic asymmetric reduction via engineered metabolic pathways and multi‐enzyme cascade

A One-Pot Biocatalytic Cascade to Access Diverse L-Phenylalanine Derivatives from Aldehydes or Carboxylic Acids

A Novel Strategy for Whole-Cell Biotransformation Enabling Simultaneous <sc>l</sc>-Phenyllactic Acid Production and Coenzyme Regeneration

One-pot enantioselective synthesis of chiral phenyllactic acids by combining stereocomplementary d- and l-lactate dehydrogenases with multi-enzyme expression fine-tuning

A tri‐enzyme cascade for efficient production of L‐2‐aminobutyrate from L‐threonine

Enzymatic Synthesis of Amoxicillin via a One-pot Enzymatic Hydrolysis and Condensation Cascade Process in the Presence of Organic Co-solvents

Construction and Application of PLP Self-sufficient Biocatalysis System for Threonine Aldolase.

A two-step, one-pot enzymatic synthesis of ampicillin from penicillin G potassium salt